About Chain Biotech
Chain Biotech is a Healthcare company based in Nottingham (United Kingdom) founded in 2014. Microbiome-based oral immunotherapies are developed via CADD platform. Chain Biotech has raised $5.88 million across 7 funding rounds from investors including BGF, SynBioVen and Miyarisan Pharmaceutical. The company has 12 employees. Chain Biotech was last valued at $5.01 million in June 2023. Chain Biotech offers products and services including CADD Platform, Oral Vaccines, and Immuno-Therapies. Its focus areas include Life Sciences, Gastroenterology, Drugs and Diversified. Its legal entity is CHAIN BIOTECHNOLOGY LIMITED.
Company details
Chain Biotech was founded in 2014 in Nottingham, United Kingdom, within the biotechnology sector. Microbiome-based oral immunotherapies are developed using the Clostridium Assisted Drug Development (CADD) platform. Precision engineering is combined with a Clostridium bacterium to enable delivery of therapeutic payloads to the lower gastrointestinal tract. Operations focus on targeted treatments for gastrointestinal conditions through this engineered approach.
- Headquarters Nottingham, United Kingdom
- Employees 12
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website chainbiotech.com
- Social LinkedIn X
- Legal Name Chain Biotechnology Limited
- Date of Incorporation 13 Jan, 2014
- Jurisdiction OXFORD
- Total Equity Funding$5.88M (USD)
in 7 rounds
- Latest Funding Round$2.32M (USD), Seed
Jun 2023
- InvestorsBGF
& 3 more
- Employee Count12
Products & Services of Chain Biotech
Chain Biotech offers a comprehensive portfolio of products and services, including CADD Platform, Oral Vaccines, and Immuno-Therapies.
Uses Clostridium bacteria to deliver therapeutic payloads to the lower GI tract.
Develops vaccines targeting the lower gastrointestinal tract for immune response.
Creates therapies for oncology and immune-oncology applications.
Funding Insights of Chain Biotech
Chain Biotech has successfully raised a total of $5.88M across 7 strategic funding rounds. The most recent funding activity was a Seed round of $2.32 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.88M
- Total Rounds 7
- Last Round Seed — $2.32M
- First Round $203,900
(Oct 2015)
- Investors Count 4
All 7 funding rounds of Chain Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Valuation | Stage |
|---|---|---|
| Jun 2023 | $5.01M | •••••••• |
| Oct 2015 | $1.02M | •••••••• |
Last known valuation $5.01M (Jun 2023). 4 investors in total: 4 institutional.
Investors in Chain Biotech
Chain Biotech has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include BGF, SynBioVen and Miyarisan Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland | bgf.co.uk | Belfast, United Kingdom | ||
| synbioven.com | ||||
Early-stage innovations are funded by UKI2S across key sectors. | ukinnovationscienceseedfund.co.uk | Manchester, United Kingdom | ||
Miyarisan Pharmaceutical is engaged in developing health solutions using butyric acid bacteria. | 1947 | miyarisan.com | Tokyo, Japan |
Investor details for Chain Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Chain Biotech
5 people are tracked at Chain Biotech (2 in leadership, 3 in board & advisors); the tracked headcount is 12.
| Name | Role | Group |
|---|---|---|
Steve Emery | Chief Scientific Officer | Leadership |
Dr. Steve Emery | Chief Scientific Officer | Leadership |
Nel Moore | Chair | Board & advisors |
Edward Green | Founder & Board Member | Board & advisors |
Robert Rickman | Non-Executive Director | Board & advisors |
Complete people profiles for Chain Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Chain Biotech
4 dated milestones of Chain Biotech across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Chain Biotech is founded.
- Funding First funding round of $204K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $2.3M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Chain Biotech
Complete news archive for Chain Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chain Biotech
Chain Biotech was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Chain Biotech is headquartered in Nottingham, United Kingdom.
Chain Biotech is a funded company, having raised a total of $5.88M across 7 funding rounds to date. The company's 1st funding round was a Seed of $203.9K, raised on Oct 2015.
Chain Biotech has 12 employees.
Chain Biotech was founded in 2014 in Nottingham, United Kingdom, within the biotechnology sector. Microbiome-based oral immunotherapies are developed using the Clostridium Assisted Drug Development (CADD) platform. Precision engineering is combined with a Clostridium bacterium to enable delivery of therapeutic payloads to the lower gastrointestinal tract. Operations focus on targeted treatments for gastrointestinal conditions through this engineered approach.
Chain Biotech offers CADD Platform, Oral Vaccines, and Immuno-Therapies.
Chain Biotech has 4 investors. Key investors include BGF, SynBioVen, Miyarisan Pharmaceutical, and UKI2S.
The valuation of Chain Biotech is $5.01M as of Jun 2023.
Chain Biotech operates through Chain Biotechnology Limited.